nafamostat has been researched along with Liver Failure, Acute in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Liver Failure, Acute: A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakae, H | 2 |
| Igarashi, T | 1 |
| Tajimi, K | 2 |
| Yonekawa, C | 1 |
| Zheng, YJ | 1 |
| Wada, H | 1 |
| Tanaka, H | 1 |
1 trial available for nafamostat and Liver Failure, Acute
| Article | Year |
|---|---|
The dose of nafamostat mesilate during plasma exchange with continuous hemodiafiltration in the series-parallel circuit.
Topics: Aged; Anticoagulants; Benzamidines; Biomarkers; Dose-Response Relationship, Drug; Female; Guanidines | 2006 |
1 other study available for nafamostat and Liver Failure, Acute
| Article | Year |
|---|---|
IL-15 levels in patients with acute hepatic failure.
Topics: Adult; Aged; Anticoagulants; Benzamidines; Bilirubin; Enzyme-Linked Immunosorbent Assay; Female; Gua | 2004 |